Skip to main content


Fig. 2 | BMC Nephrology

Fig. 2

From: Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial

Fig. 2

Changes in serum creatinine, serum albumin and 24-h proteinuria and achievement of secondary end point over the 6-month induction period. Serum creatinine expressed in mg/dL, 24-h proteinuria expressed in gram/day, serum albumin expressed in gram per dL and achievement of secondary end point in numbers. CYC- cyclophosphamide, MMF- Mycophenolate mofetil. a Change in serum creatinine. b Change in 24-h proteinuria. c Change in serum albumin. d Achievement of secondary end point

Back to article page